Emily C Addleson

A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma.

Daniel L Shaw, J. Qi, L. Rubin, 2019, Neuro-oncology.

Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomas.

D. Lauffenburger, K. Ligon, L. Griffith, 2022, Neuro-oncology advances.